Basic Information

Gene symbol CCL2 Synonyms GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF Type of gene protein-coding
Description C-C motif chemokine ligand 2

GTO ID GTC1333
Trial ID NCT00976729
Disease Systemic Lupus Erythematosus | Type 2 Diabetes Mellitus
Altered gene CCL2
Therapeutic/Target gene Target gene
TherapyAptamer
Treatment NOX-E36|Spiegelmer
PhasePhase1
Recruitment statusCompleted
TitleNOX-E36 - A Phase I, Double-Blind, Placebo Controlled, Single Intravenous and Subcutaneous Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects
Year2009
CountryGermany
Company sponsorTME Pharma AG
Other ID(s)SNOXE36C001

Clinical Result

Cohort1: dose level 1_IV
Administration route intravenous infusion
Dosage 0.03~2.0 mg/kg
Age Adult
Cohort2: dose level 2_IV
Administration route intravenous infusion
Dosage 0.09~2.0 mg/kg
Age Adult
Cohort3: dose level 3_IV
Administration route intravenous infusion
Dosage 0.25~2.0 mg/kg
Age Adult
Cohort4: dose level 4_IV
Administration route intravenous infusion
Dosage 0.5~2.0 mg/kg
Age Adult
Cohort5: dose level 5_IV
Administration route intravenous infusion
Dosage 1~2.0 mg/kg
Age Adult
Cohort6: dose level 6_IV
Administration route intravenous infusion
Dosage 2~2.0 mg/kg
Age Adult
Cohort7: dose level 3_SC
Administration route subcutaneous injections
Dosage 0.25~2.0 mg/kg
Age Adult
Cohort8: dose level 4_SC
Administration route subcutaneous injections
Dosage 0.5~2.0 mg/kg
Age Adult

Relationship Graph

Overview of Knowledge Graph